Slavica Oljačić, PhD

Dipl. farm. Slavica Filipić

Title: Assistant professor
Organizational unit: Department of Pharmaceutical Chemistry
Room: 207 (Building B)
Phone: +381 11 3951 340
E-mail: slavica.oljacic@pharmacy.bg.ac.rs

CV


Slavica Oljačić (Filipić) graduated from the University of Belgrade-Faculty of Pharmacy in 2005 with an average grade of 9.45/10.00. During her masters study she was awarded with the scholarships of the Municipality of Krupanj, and Ministry of Education of Republic of Serbia. In March 2013, she defended her PhD thesis, entitled:”Quantitative structure activity/retention relationships of imidazoline and alpha2 adrenergic receptors ligands” mentored by Professor Danica Agbaba, and Assistant Professor Katarina Nikolić, University of Belgrade-Faculty of Pharmacy. Since 2005, Slavica Oljačić has been employed at the Faculty of Pharmacy, University of Belgrade, as a Teaching Associate (2005-2007), Teaching Assistant (2007-2013) and Assistant Professor (February 2014-to date) at the Department of Pharmaceutical Chemistry. Her teaching activities are involved in the Integrated Academic Studies (Master of Pharmacy) for Pharmaceutical Chemistry II and Pharmaceutical Chemistry III (mandatory courses).

Since 2006 she has been participant in a Fundamental Research Project in the field of chemistry funded by Ministry of Education, Science and Technological Development of Republic of Serbia (142071, 172033),  as well as international projects:  two bilateral projects between the Faculty of Pharmacy, University of Belgrade, Serbia and the National Institute of Chemistry, Ljubljana, Slovenia (2005-2007, 2008-2009) and four COST (European Cooperation in Science and Technology) projects ((CA18133 (2019-2023), CA15135 (2016-2020),CM1103 (2011-2015), CM0603 (2008-2011)).

Slavica Oljačić has authored or coauthored 42 scientific papers published in international and national journals. For the purpose of professional development, she attended the Department of Biochemistry and Molecular and Cellular Biology, University of Zaragoza, Spain and the Laboratory for Food Chemistry, National Institute of Chemistry, Ljubljana, Slovenia. In 2013 she was awarded for the best scientific work at the Faculty of Pharmacy, University of Belgrade for 2012/2013 academic year.

Her main scientific research areas include: Quantitative Structure-Activity/Retention/Property Relationships studies (QSAR, QSRR, QSPR studies), molecular modeling, application of computational methods in rational drug design, application of chemometric methods for analytical methods development (HPLC, TLC, CE), and physico-chemical characterization of pharmacologically active substances.

  • Zukic S., Oljacic S.,  Nikolic K.,  Veljovic E., Spirtovic-Halilovic S., Osmanovic A., Zavrsnik D. Quantitative structure-activity relationships of xanthen-3-one and xanthen-1,8-dione derivatives and design of new compounds with enhanced antiproliferative activity on HeLa cervical cancer cells. J Biomol Struct Dyn, 2020.
  • Obradovic D., Oljacic S.,  Nikolic K.,  Agbaba D. Investigation and prediction of retention characteristics of imidazoline and serotonin receptor ligands and their related compounds on mixed-mode stationary phase. J Chromatogr A, 2019; 1585, 92-104.
  • Vucicevic J.,  Popovic M.,  Nikolic K.,  Filipic S.,  Obradovic D.,  Agbaba D. Use of biopartitioning micellar chromatography and RP-HPLC for the determination of blood-brain barrier penetration of alpha-adrenergic/imidazoline receptor ligands, and QSPR analysis. SAR QSAR Environ Res 2017, 2, 235-252.
  • Filipic S.,  Ruzic D.,  Vucicevic J.,  Nikolic K.,  Agbaba D. Quantitative structure-retention relationship of selected imidazoline derivatives on alpha(1)-acid glycoprotein column. J Pharm Biomed Anal 2016, 127, 101-111.
  • Butini S., Nikolic K., Kassel S., Brueckmann H., Filipic S., Agbaba D., Gemma S., Brogi S., Brindisi M., Campiani G., Holger S. Polypharmacology of dopamine receptor ligands, Prog Neurobiol 2016, 142, 68-103.
  • Popovic M., Popovic G.,  Filipic S.,  Nikolic K.,  Agbaba D. The effects of micelles of differently charged surfactants on the equilibrium between (Z)- and (E)-diastereomers of five ACE inhibitors in aqueous media. Monats Chem 2015, 146, 913-921.
  • Filipic B., Nikolic K., Filipic S., Jovcic B., Agbaba D., Antic Stankovic J., Kojic M.,Golic N. Identifying the CmbT substrates specificity by using a quantitative structure–activity relationship (QSAR) study. J Taiwan Inst Chem Eng 2014, 45, 764 – 771.
  • Bautista-Aguilera O. M., Samadi A., Chioua M., Nikolic K., Filipic S., Agbaba D., Soriano E., de Andrés L., Rodríguez-Franco M. I., Alcaro S., Ramsay R. R., Ortuso F., Yañez M., Marco-Contelles J.           N-Methyl-N-((1-methyl-5-(3-(1-(2-methylbenzyl)piperidin-4-yl)propoxy)-1H-indol-2-yl)methyl)prop-2-yn-1-amine, a New Cholinesterase and Monoamine Oxidase Dual Inhibitor. J Med Chem 2014, 57, 10455–10463.
  • Shenger M., Filipic S., Nikolic K.,  Agbaba D. Estimation of Lipophilicity and Retention Behavior of Some Alpha Adrenergic and Imidazoline Receptor Ligands Using RP-TLC. J Liq Chromatogr Relat Technol 2014, 37, 2829-2845.
  • Filipic S., Nikolic K., Vovk I., Krizman M., Agbaba D. Quantitative structuremobility relationship analysis of imidazoline receptor ligands in CDs-mediated CE. Electrophoresis 2013, 34, 471-482.